Cargando…
Optimization of expression conditions for a novel NZ2114-derived antimicrobial peptide-MP1102 under the control of the GAP promoter in Pichia pastoris X-33
BACKGROUND: The infections caused by antibiotic multidrug-resistant bacteria seriously threaten human health. To prevent and cure the infections caused by multidrug-resistant bacteria, new antimicrobial agents are required. Antimicrobial peptides are ideal therapy candidates for antibiotic-resistant...
Autores principales: | Mao, Ruoyu, Teng, Da, Wang, Xiumin, Zhang, Yong, Jiao, Jian, Cao, Xintao, Wang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373065/ https://www.ncbi.nlm.nih.gov/pubmed/25887810 http://dx.doi.org/10.1186/s12866-015-0389-5 |
Ejemplares similares
-
Increased intracellular activity of MP1102 and NZ2114 against Staphylococcus aureus in vitro and in vivo
por: Wang, Xiao, et al.
Publicado: (2018) -
Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus
por: Chen, Huixian, et al.
Publicado: (2017) -
In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models
por: Jiao, Jian, et al.
Publicado: (2017) -
Effect of NZ2114 against Streptococcus dysgalactiae biofilms and its application in murine mastitis model
por: Yang, Na, et al.
Publicado: (2022) -
In vitro/vivo Mechanism of Action of MP1102 With Low/Nonresistance Against Streptococcus suis Type 2 Strain CVCC 3928
por: Zhao, Fei, et al.
Publicado: (2019)